Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Retinal Diseases and Treatments, Retinal Imaging and Analysis, Retinal and Optic Conditions, and Ocular Diseases and Behçet’s Syndrome.
Infographic: Efficacy and Safety of HighDdose Intravitreal Aflibercept 8 mg in Patients with Treatment-Naïve Neovascular Age-Related Macular Degeneration: Week 96 Results from the Phase 3 PULSAR Trial.
Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years.
Association of treated neovascular AMD with disability and mood disorders: A longitudinal nationwide study.
Expert consensus on fundus fluorescein angiography reporting in ophthalmology: a Delphi study.
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in Neovascular Age-Related Macular Degeneration in Subgroups Defined by Baseline Characteristics.
Four-Year Outcomes of Faricimab in Diabetic Macular Edema: Results from the RHONE-X Extension Trial.
Impact of residual retinal fluid on treatment outcomes in neovascular age-related macular degeneration.
Ambient air pollution exposure and incidence of cataract surgery: The prospective 3City-Alienor study.
Neuroretinal and Retinal Pigment Epithelium Changes and Susceptibility to Age-Related Macular Degeneration: Insights from the Longitudinal ALIENOR Study.
Retinal Microvascular Correlates of Cerebral Small Vessel Disease in Older Age.
BRIDGE: a multi-stakeholder workstream focused on assessing new clinical endpoints in ophthalmology clinical trials [Building Research Innovations and Developing Global Endpoints].
Treatment regimens for optimising outcomes in patients with neovascular age-related macular degeneration
Improving Clinical Management of Diabetic Macular Edema: Insights from a Global Survey of Patients, Healthcare Providers, and Clinic Staff
XTEND: Two-Year Results from a Global Observational Study Investigating Proactive Dosing of Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration.
DeepAlienorNet: A deep learning model to extract clinical features from colour fundus photography in age-related macular degeneration.
Associations of drusen location with risk factors and incidence of late age-related macular degeneration in the Alienor study.
Associations of circulating vitamins with 10-year retinal neurodegeneration: the Alienor Study.
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
Association of long-term exposure to ambient air pollution with retinal neurodegeneration: the prospective Alienor study.
Optical Coherence Tomography Angiography in Diabetic Macular Edema Treated with Intravitreal Aflibercept: A 48-Week Observational Study (the DOCTA Study).
Microperimetry to predict disease progression in eyes at high risk of age-related macular degeneration disease: The PREVISION study.
Association of retinal nerve layers thickness and brain imaging in healthy young subjects from the i-Share-Bordeaux study.
Recommendations for OCT Angiography Reporting in Retinal Vascular Disease
Physical Activity, Incidence, and Progression of Age-Related Macular Degeneration: A Multicohort Study.
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Comparative Effectiveness of Intravitreal Anti-Vascular Endothelial Growth Factor Therapies for Managing Neovascular Age-Related Macular Degeneration: A Meta-Analysis.
B Vitamins and Incidence of Advanced Age-Related Macular Degeneration: The Alienor Study.
Two-year outcomes of the APOLLON observational study of intravitreal aflibercept monotherapy in France in patients with diabetic macular edema.
Analysis of Microvascular Abnormalities in Obesity: A Comparative Study with Healthy Subjects Using Swept Source Optical Coherence Tomography Angiography and Adaptive Optics.
[Hope, disappointment and questions in the treatment of AMD].